Association between prodynorphin gene polymorphisms and opioid dependence susceptibility: a meta-analysis

Area of Science:

• Genetics
• Pharmacology
• Addiction Medicine

Background:

• Prodynorphin (PDYN) gene polymorphisms are implicated in opioid dependence (OD).
• Previous studies on the association between PDYN polymorphisms and OD susceptibility have yielded conflicting results.
• This study aims to synthesize existing evidence to clarify the relationship.

Purpose of the Study:

• To conduct a meta-analysis synthesizing evidence on the association between Prodynorphin (PDYN) gene polymorphisms and opioid dependence (OD) susceptibility.
• To evaluate the overall impact of specific PDYN polymorphisms on OD risk.

Main Methods:

• A systematic literature search was conducted across PubMed, EMBASE, Web of Science, and Wanfang databases.
• Seven case-control studies comprising 3129 cases and 3289 controls were included in the meta-analysis.
• Statistical analysis using summary odds ratios (OR) and 95% confidence intervals (95%CI) was performed with RevMan 5.3 software.

Main Results:

• The rs910080 polymorphism in the PDYN gene showed a significant correlation with opioid dependence in the Asian population under allelic and dominant models.
• Specifically, for rs910080, ORs were 1.30 (95% CI 1.04-1.62) and 1.25 (95% CI 1.04-1.51) respectively.
• No significant association was found between OD susceptibility and rs1022563, rs1997794, or rs2235749 polymorphisms.

Conclusions:

• A significant association exists between the PDYN rs910080 polymorphism and opioid dependence in the Asian population.
• The current evidence base is limited, necessitating larger sample sizes and broader ethnic representation in future studies.
• Further investigation is recommended to confirm and expand upon these findings.